ICU Sedation After Coronary Artery Bypass Graft Surgery: Dexmedetomidine-Based Versus Propofol-Based Sedation Regimens

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 17, Issue 5, 2003, Pages 576-584

  Herr, Daniel L ^a   Sum Ping, S T John ^b   England, Michael ^c  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Alpha2 adrenoceptors; Cardiac artery bypass graft; Imidazoles; Sedation; Sympatholysis

Indexed keywords

ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; ANTIEMETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DEXMEDETOMIDINE; DIURETIC AGENT; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PROPOFOL;

ACIDOSIS; ADULT; AGITATION; ANEMIA; ARTICLE; ATELECTASIS; BLEEDING; BLOOD PRESSURE; BRADYCARDIA; BREATHING RATE; BRONCHOSPASM; CLINICAL TRIAL; CONFUSION; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DOUBLE BLIND PROCEDURE; DRUG POTENTIATION; EXTUBATION; FEMALE; FEVER; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART RATE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOCALCEMIA; HYPOTENSION; HYPOVOLEMIA; HYPOXIA; INTENSIVE CARE UNIT; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OLIGURIA; PAIN; PERICARDITIS; PERIPHERAL EDEMA; PLEURA EFFUSION; PNEUMOTHORAX; POSTOPERATIVE CARE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESPIRATION DEPRESSION; RIGOR; SEDATION; STERNUM; TACHYCARDIA; VOMITING; WOUND CLOSURE; XEROSTOMIA;

EID: 0142031128     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(03)00200-3     Document Type: Article

References (48)

1. Ostermann ME, Keenan SP, Seiferling RA, et al: Sedation in the intensive care unit: A systematic review. JAMA 283:1451-1459, 2000
2. Westcott C: The sedation of patients in intensive care units: A nursing review. Intensive Crit Care Nurse 11:26-31, 1995
3. Bair N, Bobek MB, Hoffman-Hogg L, et al: Introduction of sedative, analgesic, and neuromuscular blocking agent guidelines in a medical intensive care unit: physician and nurse adherence (see comments). Crit Care Med 28:707-713, 2000
4. , Berger JT, Rosner F: The ethics of practice guidelines. Arch Intern Med 156:2051-2056, 1996
5. Dasta JF, Fuhrman TM, McCandles C: Patterns of prescribing and administering drugs for agitation and pain in patients in a surgical intensive care unit. Crit Care Med 22:974-980, 1994
6. Young C, Knudsen N, Hilton A, et al: Sedation in the intensive care unit. Crit Care Med 28:854-866, 2000
7. Kollef MH, Levy NT, Ahrens TS, et al: The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest 114:541-548, 1998
8. Kress JP, Christenson J, Pohlman AS, et al: Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 160:1957-1961, 1999
9. Claeys MA, Gepts E, Camu F: Haemodynamic changes during anaesthesia induced and maintained with propofol. Br J Anaesth 60:3-9, 1988
10. Aitkenhead AR, Pepperman ML, Willatts SM, et al: Comparison of propofol and midazolam for sedation in critically ill patients. Lancet 2:704-709, 1989
11. Barr J, Donner A: Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit. Crit Care Clin 11:827-847, 1995
12. Leino K, Mildh L, Lertola K, et al: Time course of changes in breathing pattern in morphine- and oxycodone-induced respiratory depression. Anaesthesia 54:835-840, 1999
13. 2-adrenergic receptors. Anaesth Pharmacol Rev 1:233-237, 1993
14. Testa LD, Tobias JD: Pharmacologic drugs for controlled hypotension. J Clin Anesth 7:326-337, 1995
15. Zhang YH, Zhu J, Song YC: Suppressing sympathetic activation with clonidine on ventricular arrhythmias in congestive heart failure. Int J Cardiol 65:233-238, 1998
16. 2-adrenoceptor agonist. Eur J Pharmacol 150:9-14, 1988
17. Venn RM, Bradshaw CJ, Spencer R, et al: Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 54:1136-1142, 1999
18. 2-agonist, dexmedetomidine, in anesthesia and analgesia, in 11th World Congress of Anaesthesiologists, Sydney, Australia. Anesth Analg 661, 1996
19. Hall JE, Uhrich TD, Barney JA, et al: Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 90:699-705, 2000
20. 2-adrenergic agonists. Anesthesiology 93:345-1349, 2000
21. Venn RM, Hell J, Grounds RM: Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 4:302-308, 2000
22. Bradley C: Dexmedetomidine-A novel sedative for postoperative sedation. Intensive Crit Care Nurs 16:328-329, 2000
23. Colombo JA, Lewis KS, Rothenberg DM, et al: Dexmedetomidine as monotherapy for sedation after cardiac surgery in the intensive care unit. Anesthesiology 95:A381, 2001 (abstr)
24. Ebert TJ, Hall JE, Barney JA, et al: The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93:382-394, 2000
25. Maze M, Guo TZ, Buttermann AE: Dexmedetomidine injection into the locus coeruleus produces analgesia. Anesthesiology 83:A731, 1995 (abstr)
26. Ramsay MAE, Savege TM, Simpson BRJ, et al: Controlled sedation with alphaxalone-alphadolone. Br Med J 2:656-659, 1974
27. Triltsch AE, Welte M, von Homeyer P, et al: Bispectral index-guided sedation with dexmedetomidine in intensive care: A prospective, randomized, double-blind, placebo-controlled phase II study. Crit Care Med 30:1007-1014, 2002
28. 2-adrenoceptor agonist dexmedetomidine in post-surgical sedation in the ICU. J Intensive Care Med 18:29-41, 2003
29. 2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 54:146-165, 1999
30. 2-adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. Anesthesiology 86:346-363, 1997
31. Maze M, Scarfini C, Cavaliere F: New agents for sedation in the intensive care unit. Crit Care Clin 17:881-897, 2001
32. Lawrence CJ, Prinzen FW, De Lange S: The effect of dexmedetomidine on the balance of myocardial energy requirement and oxygen supply and demand. Anesth Analg 82:544-550, 1996
33. Venn RM, Bryant A, Hall GM, et al: Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in postoperative patients needing sedation in the intensive care unit. Br J Anaesth 86:650-656, 2001
34. Venn RM, Grounds RM: Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: Patient and clinician perceptions. Br J Anaesth 87:654-690, 2001
35. 2-adrenergic agonists and perioperative ischaemia. Anaesth Pharmacol Rev 1:310-315, 1993
36. Mangano DT: Perioperative cardiovascular morbidity: new developments. Bailliere's Clin Anaesth 13:335-338, 1999
37. Oliver M, Goldman B, Julian D, et al: Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease. The European Mivazerol Trial (FMIT). Anesthesiology 91:951-961, 1999
38. 2-agonists and analgesia. Expert Opin Invest Drugs 3:1005-1010, 1994
39. Belleville JP, Ward DS, Bloor BC, et al: Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 77:1125-1133, 1992
40. 2-adrenergic agonist, dexmedetomidine. Neuropharmacology 30:1065-1071, 1991
41. Jarvis DA, Duncan SR, Segal IS, et al: Ventilatory effects of clonidine alone and in the presence of alfentanil, in human volunteers. Anesthesiol 76:899-905, 1992
42. 2-adrenergic agonists during general anaesthesia. Anaesth Pharmacol Rev 1:268-283, 1993
43. Talke P, Chen R, Thomas B, et al: The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg 90:834-839, 2000
44. de Lemos J, Tweeddale M, Chittock D: Measuring quality of sedation in adult mechanically ventilated critically ill patients. The Vancouver Interaction and Calmness Scale Sedation Focus Group. J Clin Epidemiol 53:908-919, 2000
45. Coursin DB, Maccioli GA: Dexmedetomidine. Curr Opin Crit Care 7:221-226, 2001
46. 2-agonist, dexmedetomidine? in Anaesthesia Research Society Meeting, London, England. Br J Anaesth 247, 2001
47. 2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: Results of a randomized, controlled trial. Crit Care Med 24:947-952, 1996
48. 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology 73:230-235, 1990